Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NTP is a highly non-specific abbreviation that refers to several distinct entities, some of which are pharmaceutical drugs or drug-related. In clinical contexts, "NTP" can refer to Nitroglycerin or Sodium Nitroprusside, both of which are vasodilators. Nitroglycerin is used topically or intraarterially to prevent radial artery occlusion, while Sodium Nitroprusside is administered intravenously for conditions like right heart failure. "NTP" also designates 99mTc-NTP 15-5, a radiopharmaceutical tracer used for imaging cartilage in conditions like osteoarthritis and breast cancer. Furthermore, "NTP" stands for nucleoside triphosphate, a class of biochemical molecules that serve as building blocks for RNA. Modified nucleoside triphosphates, such as arabinose nucleotides (ara-NTP), have been investigated as antiviral agents, inhibiting viral polymerases by inducing prolonged pauses during RNA elongation. Other uses of "NTP" in the provided context include Non-thermal plasma (a physical treatment modality), Neuromuscular Training Programs (behavioral interventions), and as part of diagnostic test names or organizational acronyms, which are not considered drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NTP.